Global Gene Editing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

July 2024 | 111 pages | ID: G3B4F070EEA5EN
GlobalInfoResearch

Abstracts

According to our latest research, the global Gene Editing market size will reach USD 5301 million in 2030, growing at a CAGR of 7.6% over the analysis period.

Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.

The Gene Editing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

Market segmentation

Gene Editing market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• Zinc finger nucleases (ZFNs)
• Transcription Activator-Like Effector-based Nucleases (TALENs)
• CRISPR-Cas system

Market segment by Application, can be divided into

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations

Market segment by players, this report covers

• Thermo Fisher Scientific
• Merck
• Horizo??n Discovery
• Sangamo BioSciences
• Integrated DNA Technologies
• Lonza
• New England Biolabs
• OriGene Technologies
• Transposagen Biopharmaceuticals
• Editas Medicine
• CRISPR Therapeutics
• RGen Solutions
• Sigma-Aldrich
• GeneCopoeia
• Genscript Biotech

Market segment by regions, regional analysis covers

• North America
• Europe
• Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
• South America
• Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Gene Editing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Gene Editing, with recent developments and future plans

Chapter 3, the Gene Editing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Gene Editing market forecast, by regions, with revenue, from 2024 to 2030.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.

Chapter 7 and 8, to describe Gene Editing research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Gene Editing
1.2 Classification of Gene Editing by Type
  1.2.1 Overview: Global Gene Editing Market Size by Type: 2024 Versus 2030
  1.2.2 Global Gene Editing Revenue Market Share by Type in 2030
  1.2.3 Zinc finger nucleases (ZFNs)
  1.2.4 Transcription Activator-Like Effector-based Nucleases (TALENs)
  1.2.5 CRISPR-Cas system
1.3 Global Gene Editing Market by Application
  1.3.1 Overview: Global Gene Editing Market Size by Application: 2024 Versus 2030
  1.3.2 Biotechnology & Pharmaceutical Companies
  1.3.3 Academic & Government Research Institutes
  1.3.4 Contract Research Organizations
1.4 Global Gene Editing Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Gene Editing Market Drivers
  1.5.2 Gene Editing Market Restraints
  1.5.3 Gene Editing Trends Analysis

2 COMPANY PROFILES

2.1 Thermo Fisher Scientific
  2.1.1 Thermo Fisher Scientific Details
  2.1.2 Thermo Fisher Scientific Major Business
  2.1.3 Thermo Fisher Scientific Gene Editing Product and Solutions
  2.1.4 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
  2.2.1 Merck Details
  2.2.2 Merck Major Business
  2.2.3 Merck Gene Editing Product and Solutions
  2.2.4 Merck Recent Developments and Future Plans
2.3 Horizo??n Discovery
  2.3.1 Horizo??n Discovery Details
  2.3.2 Horizo??n Discovery Major Business
  2.3.3 Horizo??n Discovery Gene Editing Product and Solutions
  2.3.4 Horizo??n Discovery Recent Developments and Future Plans
2.4 Sangamo BioSciences
  2.4.1 Sangamo BioSciences Details
  2.4.2 Sangamo BioSciences Major Business
  2.4.3 Sangamo BioSciences Gene Editing Product and Solutions
  2.4.4 Sangamo BioSciences Recent Developments and Future Plans
2.5 Integrated DNA Technologies
  2.5.1 Integrated DNA Technologies Details
  2.5.2 Integrated DNA Technologies Major Business
  2.5.3 Integrated DNA Technologies Gene Editing Product and Solutions
  2.5.4 Integrated DNA Technologies Recent Developments and Future Plans
2.6 Lonza
  2.6.1 Lonza Details
  2.6.2 Lonza Major Business
  2.6.3 Lonza Gene Editing Product and Solutions
  2.6.4 Lonza Recent Developments and Future Plans
2.7 New England Biolabs
  2.7.1 New England Biolabs Details
  2.7.2 New England Biolabs Major Business
  2.7.3 New England Biolabs Gene Editing Product and Solutions
  2.7.4 New England Biolabs Recent Developments and Future Plans
2.8 OriGene Technologies
  2.8.1 OriGene Technologies Details
  2.8.2 OriGene Technologies Major Business
  2.8.3 OriGene Technologies Gene Editing Product and Solutions
  2.8.4 OriGene Technologies Recent Developments and Future Plans
2.9 Transposagen Biopharmaceuticals
  2.9.1 Transposagen Biopharmaceuticals Details
  2.9.2 Transposagen Biopharmaceuticals Major Business
  2.9.3 Transposagen Biopharmaceuticals Gene Editing Product and Solutions
  2.9.4 Transposagen Biopharmaceuticals Recent Developments and Future Plans
2.10 Editas Medicine
  2.10.1 Editas Medicine Details
  2.10.2 Editas Medicine Major Business
  2.10.3 Editas Medicine Gene Editing Product and Solutions
  2.10.4 Editas Medicine Recent Developments and Future Plans
2.11 CRISPR Therapeutics
  2.11.1 CRISPR Therapeutics Details
  2.11.2 CRISPR Therapeutics Major Business
  2.11.3 CRISPR Therapeutics Gene Editing Product and Solutions
  2.11.4 CRISPR Therapeutics Recent Developments and Future Plans
2.12 RGen Solutions
  2.12.1 RGen Solutions Details
  2.12.2 RGen Solutions Major Business
  2.12.3 RGen Solutions Gene Editing Product and Solutions
  2.12.4 RGen Solutions Recent Developments and Future Plans
2.13 Sigma-Aldrich
  2.13.1 Sigma-Aldrich Details
  2.13.2 Sigma-Aldrich Major Business
  2.13.3 Sigma-Aldrich Gene Editing Product and Solutions
  2.13.4 Sigma-Aldrich Recent Developments and Future Plans
2.14 GeneCopoeia
  2.14.1 GeneCopoeia Details
  2.14.2 GeneCopoeia Major Business
  2.14.3 GeneCopoeia Gene Editing Product and Solutions
  2.14.4 GeneCopoeia Recent Developments and Future Plans
2.15 Genscript Biotech
  2.15.1 Genscript Biotech Details
  2.15.2 Genscript Biotech Major Business
  2.15.3 Genscript Biotech Gene Editing Product and Solutions
  2.15.4 Genscript Biotech Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Gene Editing Revenue and Share by Players (2024 & 2030)
3.2 Gene Editing Players Head Office, Products and Services Provided
3.3 Gene Editing Mergers & Acquisitions
3.4 Gene Editing New Entrants and Expansion Plans

4 GLOBAL GENE EDITING FORECAST BY REGION

4.1 Global Gene Editing Market Size by Region: 2024 VS 2030
4.2 Global Gene Editing Market Size by Region, (2024-2030)
4.3 North America
  4.3.1 Key Companies of Gene Editing in North America
  4.3.2 Current Situation and Forecast of Gene Editing in North America
  4.3.3 North America Gene Editing Market Size and Prospect (2024-2030)
4.4 Europe
  4.4.1 Key Companies of Gene Editing in Europe
  4.4.2 Current Situation and Forecast of Gene Editing in Europe
  4.4.3 Europe Gene Editing Market Size and Prospect (2024-2030)
4.5 Asia-Pacific
  4.5.1 Key Companies of Gene Editing in Asia-Pacific
  4.5.2 Current Situation and Forecast of Gene Editing in Asia-Pacific
  4.5.3 Asia-Pacific Gene Editing Market Size and Prospect (2024-2030)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Gene Editing in South America
  4.6.2 Current Situation and Forecast of Gene Editing in South America
  4.6.3 South America Gene Editing Market Size and Prospect (2024-2030)
4.7 Middle East & Africa
  4.7.1 Key Companies of Gene Editing in Middle East & Africa
  4.7.2 Current Situation and Forecast of Gene Editing in Middle East & Africa
  4.7.3 Middle East & Africa Gene Editing Market Size and Prospect (2024-2030)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Gene Editing Market Forecast by Type (2024-2030)
5.2 Global Gene Editing Market Share Forecast by Type (2024-2030)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Gene Editing Market Forecast by Application (2024-2030)
6.2 Global Gene Editing Market Share Forecast by Application (2024-2030)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Gene Editing Revenue by Type, (USD Million), 2024 VS 2030
Table 2. Global Gene Editing Revenue by Application, (USD Million), 2024 VS 2030
Table 3. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 4. Thermo Fisher Scientific Major Business
Table 5. Thermo Fisher Scientific Gene Editing Product and Solutions
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck Gene Editing Product and Solutions
Table 9. Horizo??n Discovery Corporate Information, Head Office, and Major Competitors
Table 10. Horizo??n Discovery Major Business
Table 11. Horizo??n Discovery Gene Editing Product and Solutions
Table 12. Sangamo BioSciences Corporate Information, Head Office, and Major Competitors
Table 13. Sangamo BioSciences Major Business
Table 14. Sangamo BioSciences Gene Editing Product and Solutions
Table 15. Integrated DNA Technologies Corporate Information, Head Office, and Major Competitors
Table 16. Integrated DNA Technologies Major Business
Table 17. Integrated DNA Technologies Gene Editing Product and Solutions
Table 18. Lonza Corporate Information, Head Office, and Major Competitors
Table 19. Lonza Major Business
Table 20. Lonza Gene Editing Product and Solutions
Table 21. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 22. New England Biolabs Major Business
Table 23. New England Biolabs Gene Editing Product and Solutions
Table 24. OriGene Technologies Corporate Information, Head Office, and Major Competitors
Table 25. OriGene Technologies Major Business
Table 26. OriGene Technologies Gene Editing Product and Solutions
Table 27. Transposagen Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 28. Transposagen Biopharmaceuticals Major Business
Table 29. Transposagen Biopharmaceuticals Gene Editing Product and Solutions
Table 30. Editas Medicine Corporate Information, Head Office, and Major Competitors
Table 31. Editas Medicine Major Business
Table 32. Editas Medicine Gene Editing Product and Solutions
Table 33. CRISPR Therapeutics Corporate Information, Head Office, and Major Competitors
Table 34. CRISPR Therapeutics Major Business
Table 35. CRISPR Therapeutics Gene Editing Product and Solutions
Table 36. RGen Solutions Corporate Information, Head Office, and Major Competitors
Table 37. RGen Solutions Major Business
Table 38. RGen Solutions Gene Editing Product and Solutions
Table 39. Sigma-Aldrich Corporate Information, Head Office, and Major Competitors
Table 40. Sigma-Aldrich Major Business
Table 41. Sigma-Aldrich Gene Editing Product and Solutions
Table 42. GeneCopoeia Corporate Information, Head Office, and Major Competitors
Table 43. GeneCopoeia Major Business
Table 44. GeneCopoeia Gene Editing Product and Solutions
Table 45. Genscript Biotech Corporate Information, Head Office, and Major Competitors
Table 46. Genscript Biotech Major Business
Table 47. Genscript Biotech Gene Editing Product and Solutions
Table 48. Global Gene Editing Revenue (USD Million) by Players (2024 & 2030)
Table 49. Global Gene Editing Revenue Share by Players (2024 & 2030)
Table 50. Gene Editing Players Head Office, Products and Services Provided
Table 51. Gene Editing Mergers & Acquisitions in the Past Five Years
Table 52. Gene Editing New Entrants and Expansion Plans
Table 53. Global Market Gene Editing Revenue (USD Million) Comparison by Region (2024 VS 2030)
Table 54. Global Gene Editing Revenue Market Share by Region (2024-2030)
Table 55. Key Companies of Gene Editing in North America
Table 56. Current Situation and Forecast of Gene Editing in North America
Table 57. Key Companies of Gene Editing in Europe
Table 58. Current Situation and Forecast of Gene Editing in Europe
Table 59. Key Companies of Gene Editing in Asia-Pacific
Table 60. Current Situation and Forecast of Gene Editing in Asia-Pacific
Table 61. Key Companies of Gene Editing in China
Table 62. Key Companies of Gene Editing in Japan
Table 63. Key Companies of Gene Editing in South Korea
Table 64. Key Companies of Gene Editing in South America
Table 65. Current Situation and Forecast of Gene Editing in South America
Table 66. Key Companies of Gene Editing in Middle East & Africa
Table 67. Current Situation and Forecast of Gene Editing in Middle East & Africa
Table 68. Global Gene Editing Revenue Forecast by Type (2024-2030)
Table 69. Global Gene Editing Revenue Forecast by Application (2024-2030)

List Of Figures

LIST OF FIGURES

Figure 1. Gene Editing Picture
Figure 2. Global Gene Editing Revenue Market Share by Type in 2030
Figure 3. Zinc finger nucleases (ZFNs)
Figure 4. Transcription Activator-Like Effector-based Nucleases (TALENs)
Figure 5. CRISPR-Cas system
Figure 6. Gene Editing Revenue Market Share by Application in 2030
Figure 7. Biotechnology & Pharmaceutical Companies Picture
Figure 8. Academic & Government Research Institutes Picture
Figure 9. Contract Research Organizations Picture
Figure 10. Global Gene Editing Market Size, (USD Million): 2024 VS 2030
Figure 11. Global Gene Editing Revenue and Forecast (2024-2030) & (USD Million)
Figure 12. Gene Editing Market Drivers
Figure 13. Gene Editing Market Restraints
Figure 14. Gene Editing Market Trends
Figure 15. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 16. Merck Recent Developments and Future Plans
Figure 17. Horizo??n Discovery Recent Developments and Future Plans
Figure 18. Sangamo BioSciences Recent Developments and Future Plans
Figure 19. Integrated DNA Technologies Recent Developments and Future Plans
Figure 20. Lonza Recent Developments and Future Plans
Figure 21. New England Biolabs Recent Developments and Future Plans
Figure 22. OriGene Technologies Recent Developments and Future Plans
Figure 23. Transposagen Biopharmaceuticals Recent Developments and Future Plans
Figure 24. Editas Medicine Recent Developments and Future Plans
Figure 25. CRISPR Therapeutics Recent Developments and Future Plans
Figure 26. RGen Solutions Recent Developments and Future Plans
Figure 27. Sigma-Aldrich Recent Developments and Future Plans
Figure 28. GeneCopoeia Recent Developments and Future Plans
Figure 29. Genscript Biotech Recent Developments and Future Plans
Figure 30. Global Gene Editing Revenue Market Share by Region (2024-2030)
Figure 31. Global Gene Editing Revenue Market Share by Region in 2030
Figure 32. North America Gene Editing Revenue (USD Million) and Growth Rate (2024-2030)
Figure 33. Europe Gene Editing Revenue (USD Million) and Growth Rate (2024-2030)
Figure 34. Asia-Pacific Gene Editing Revenue (USD Million) and Growth Rate (2024-2030)
Figure 35. South America Gene Editing Revenue (USD Million) and Growth Rate (2024-2030)
Figure 36. Middle East & Africa Gene Editing Revenue (USD Million) and Growth Rate (2024-2030)
Figure 37. Global Gene Editing Market Share Forecast by Type (2024-2030)
Figure 38. Global Gene Editing Market Share Forecast by Application (2024-2030)
Figure 39. Methodology
Figure 40. Research Process and Data Source